Maala Bhatt

Maala Bhatt

Auto-generated profile, based on publicly available information

Maala Bhatt

Department of Pediatrics, Children’s Hospital of Eastern Ontario, Ottawa, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
MBMaala Bhatt
Maala Bhatt
DJDavid W. Johnson
David W. Johnson
JCJason Chan
Jason Chan
MTMonica Taljaard
Monica Taljaard
NBNick Barrowman
Nick Barrowman
F(for the Sedation Safety Study Group of Pediatric Emergency Research Canada (PERC)
for the Sedation Safety Study Group of Pediatric Emergency Research Canada (PERC)
Procedural pain and anxiety relief is an ethical imperative in the treatment of children given that children have short- and long-term physical, physiological, and psychological effects due to untreated pain.1-3 As such, procedural sedation, defined as the administration of medications to minimize pain and awareness, has become standard practice in pediatric emergency departments (EDs) worldwide to facilitate procedures, such as orthopedic reduction and complex laceration repairs.4-8 Although ED sedation is regarded as safe, it has been associated with serious adverse events (SAEs).6,9 The incidence of SAEs has been difficult to determine because of their infrequent occurrence and the lack of large, multicenter surveillance studies focused on systematic detection of adverse events. Previous ED sedation studies, limited by single-center design and small sample sizes, have not been able to reliably associate their use with sedation-related adverse events, their severity, or their outcomes for patients.9-12

1 July 2018 in JAMA Pediatrics
Verified
Journal Article
Closed access
MBMaala Bhatt
Maala Bhatt
DJDavid Johnson
David Johnson
MTMonica Taljaard
Monica Taljaard
JCJason Chan
Jason Chan
NBNick Barrowman
Nick Barrowman
FCfor the Sedation Safety Study Group of Pediatric Emergency Research Canada
for the Sedation Safety Study Group of Pediatric Emergency Research Canada
Importance It is not clear whether adherence to preprocedural fasting guidelines prevent pulmonary aspiration and associated adverse outcomes during emergency department (ED) sedation of children. Objective To examine the association between preprocedural fasting duration and the incidence of sedation-related adverse outcomes in a large sample of children. Design, Setting, and Participants We conducted a planned secondary analysis of a multicenter prospective cohort study of children aged 0 to 18 years who received procedural sedation for a painful procedure in 6 Canadian pediatric EDs from July 2010 to February 2015. The primary risk factor was preprocedural fasting duration. Secondary risk factors were age, sex, American Society of Anesthesiologists classification, preprocedural and sedation medications, and procedure type. Main Outcomes and Measures Four outcomes were examined: (1) pulmonary aspiration, (2) the occurrence of any adverse event, (3) serious adverse events, and (4) vomiting. Results A total of 6183 children with a median age of 8.0 years (interquartile range, 4.0-12.0 years), of whom 6166 (99.7%) had healthy or mild systemic disease (American Society of Anesthesiologists levels I or II), were included in the analysis. Of these, 2974 (48.1%) and 310 (5.0%) children did not meet American Society of Anesthesiologists fasting guidelines for solids and liquids, respectively. There were no cases of pulmonary aspiration. There were 717 adverse events (11.6%; 95% CI, 10.8%-12.4%), of which 68 (1.1%; 95% CI, 0.9%-1.3%) were serious adverse events and 315 (5.1%; 95% CI, 4.6%-5.7%) were vomiting. The odds ratio (OR) of occurrence of any adverse event, serious adverse events, and vomiting did not change significantly with each additional hour of fasting duration for both solids (any adverse event: OR, 1.00; 95% CI, 0.98 to 1.02; serious adverse events, OR, 1.01; 95% CI, 0.95-1.07; vomiting: OR, 1.00; 95% CI, 0.97-1.03) and liquids (any adverse event: OR, 1.00; 95% CI, 0.98-1.02; serious adverse events: 1.01, 95% CI, 0.95-1.07; vomiting: OR, 1.00; 95% CI, 0.96-1.03). Conclusions and Relevance In this study, there was no association between fasting duration and any type of adverse event. These findings do not support delaying sedation to meet established fasting guidelines.

12 April 2022 in CMAJ Open
Verified
Journal Article
Open access
PDF file
MBMaala Bhatt
Maala Bhatt
APAmy C. Plint
Amy C. Plint
KTKen Tang
Ken Tang
RMRichard Malley
Richard Malley
AHAnne Pham Huy
Anne Pham Huy
RZRoger L. Zemek
Roger L. Zemek
Background: Household transmission contributes to SARS-CoV-2 spread, but the role of children in transmission is unclear. We conducted a study that included symptomatic and asymptomatic children and adults exposed to SARS-CoV-2 in their households with the objective of determining how SARS-CoV-2 is transmitted within households. Methods: In this case-ascertained antibody-surveillance study, we enrolled households in Ottawa, Ontario, in which at least 1 household member had tested positive for SARS-CoV-2 on reverse transcription polymerase chain reaction testing. The enrolment period was September 2020 to March 2021. Potentially eligible participants were identified if they had tested positive for SARS-CoV-2 at an academic emergency department or affiliated testing centre; people who learned about the study through the media could also self-identify for participation. At least 2 participants were required for a household to be eligible for study participation, and at least 1 enrolled participant per household had to be a child (age < 18 yr). Enzyme-linked immunosorbent assays were used to evaluate SARS-CoV-2-specific IgA, IgM and IgG against the spike-trimer and nucleocapsid protein. The primary outcome was household secondary attack rate, defined as the proportion of household contacts positive for SARS-CoV-2 antibody among the total number of household contacts participating in the study. We performed descriptive statistics at both the individual and household levels. To estimate and compare outcomes between patient subgroups, and to examine predictors of household transmission, we fitted a series of multivariable logistic regression with robust standard errors to account for clustering of individuals within households. Results: We enrolled 695 participants from 180 households: 180 index participants (74 children, 106 adults) and 515 of their household contacts (266 children, 249 adults). A total of 487 household contacts (94.6%) (246 children, 241 adults) had SARS-CoV-2 antibody testing, of whom 239 had a positive result (secondary attack rate 49.1%, 95% confidence interval [CI] 42.9%–55.3%). Eighty-eight (36.8%, 95% CI 29.3%–43.2%) of the 239 were asymptomatic; asymptomatic rates were similar for children (51/130 [39.2%, 95% CI 30.7%–48.5%]) and adults (37/115 [32.2%, 95% CI 24.2%–41.4%]) (odds ratio [OR] 1.3, 95% CI 0.8–2.1). Adults were more likely than children to transmit SARS-CoV-2 (OR 2.2, 95% CI 1.3–3.6). The odds of transmission from asymptomatic (OR 0.6, 95% CI 0.2–1.4) versus symptomatic (OR 0.9, 95% CI 0.6–1.4) index participants to household contacts was uncertain. Predictors of household transmission included household density (number of people per bedroom), relationship to index participant and number of cases in the household. Interpretation: The rate of SARS-CoV-2 transmission within households was nearly 50% during the study period, and children were an important source of spread. The findings suggest that children are an important driver of the COVID-19 pandemic; this should inform public health policy.

1 January 2020 in Academic Emergency Medicine
Verified
Journal Article
Closed access
PDF file
MBMaala Bhatt
Maala Bhatt
WCWei Cheng
Wei Cheng
MRMark G. Roback
Mark G. Roback
DJDavid W. Johnson
David W. Johnson
MTMonica Taljaard
Monica Taljaard
GAGabrielle Allard
Gabrielle Allard

29 May 2015 in BMJ Open
Verified
Journal Article
Open access
PDF file
MBMaala Bhatt
Maala Bhatt
MRMark G Roback
Mark G Roback
GJGary Joubert
Gary Joubert
KFKen J Farion
Ken J Farion
SASamina Ali
Samina Ali
DJDavid W Johnson
David W Johnson
Introduction Procedural sedation and analgesia have become standard practice in paediatric emergency departments worldwide. Although generally regarded as safe, serious adverse events such as bradycardia, asystole, pulmonary aspiration, permanent neurological injury and death have been reported, but their incidence is unknown due to the infrequency of their occurrence and lack of surveillance of sedation safety. To improve our understanding of the safety, comparative effectiveness and variation in care in paediatric procedural sedation, we are establishing a multicentre patient registry with the goal of conducting regular and ongoing surveillance for adverse events in procedural sedation. Methods This multicentre, prospective cohort study is enrolling patients under 18 years of age from six paediatric emergency departments across Canada. Data collection is fully integrated into clinical care and is performed electronically in real time by the healthcare professionals caring for the patient. The primary outcome is the proportion of patients who experience a serious adverse event as a result of their sedation. Secondary outcomes include the proportion of patients who experience an adverse event that could lead to a serious adverse event, proportion of patients who receive a significant intervention in response to an adverse event, proportion of patients who experience a successful sedation, and proportion of patients who experience a paradoxical reaction to sedation. There is no predetermined end date for data collection. Ethics and dissemination Ethics approval has been obtained from participating sites. Results will be disseminated using a multifaceted knowledge translation strategy by presenting at international conferences, publication in peer-reviewed journals, and through established networks.

1 August 2021 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
MSMichael Schlegelmilch
Michael Schlegelmilch
MRMark G. Roback
Mark G. Roback
MBMaala Bhatt
Maala Bhatt
DJDavid W. Johnson
David W. Johnson
KFKen J. Farion
Ken J. Farion
GAGabrielle Allard
Gabrielle Allard